355 related articles for article (PubMed ID: 9253779)
1. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue.
Cella D
Semin Hematol; 1997 Jul; 34(3 Suppl 2):13-9. PubMed ID: 9253779
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing quality of life in cancer patients: anemia and fatigue.
Cella D
Semin Oncol; 1998 Jun; 25(3 Suppl 7):43-6. PubMed ID: 9671330
[TBL] [Abstract][Full Text] [Related]
3. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
[TBL] [Abstract][Full Text] [Related]
4. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841
[TBL] [Abstract][Full Text] [Related]
5. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system.
Yellen SB; Cella DF; Webster K; Blendowski C; Kaplan E
J Pain Symptom Manage; 1997 Feb; 13(2):63-74. PubMed ID: 9095563
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life measures in routine clinical care: can FACT-fatigue help to assess the management of fatigue in cancer patients?
Santana MJ; Au HJ; Dharma-Wardene M; Hewitt JD; Dupere D; Hanson J; Ghosh S; Feeny D
Int J Technol Assess Health Care; 2009 Jan; 25(1):90-6. PubMed ID: 19126256
[TBL] [Abstract][Full Text] [Related]
7. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.
Crawford J; Cella D; Cleeland CS; Cremieux PY; Demetri GD; Sarokhan BJ; Slavin MB; Glaspy JA
Cancer; 2002 Aug; 95(4):888-95. PubMed ID: 12209734
[TBL] [Abstract][Full Text] [Related]
8. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.
Straus DJ; Testa MA; Sarokhan BJ; Czuczman MS; Tulpule A; Turner RR; Riggs SA
Cancer; 2006 Oct; 107(8):1909-17. PubMed ID: 16977654
[TBL] [Abstract][Full Text] [Related]
9. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
10. Quality of life assessment in nonmelanoma cervicofacial skin cancer.
Rhee JS; Loberiza FR; Matthews BA; Neuburg M; Smith TL; Burzynski M
Laryngoscope; 2003 Feb; 113(2):215-20. PubMed ID: 12567071
[TBL] [Abstract][Full Text] [Related]
11. The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study.
Strasser F; Palmer JL; Schover LR; Yusuf SW; Pisters K; Vassilopoulou-Sellin R; DeGracia B; Willey JS; Bruera E
Cancer; 2006 Dec; 107(12):2949-57. PubMed ID: 17103445
[TBL] [Abstract][Full Text] [Related]
12. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
[TBL] [Abstract][Full Text] [Related]
13. Quality-of-life measurement in patients undergoing radiation therapy for head and neck cancer: a Hong Kong experience.
Lo PS; Lo SK; Tong MC; Ku PK; Leung SF; van Hasselt CA
J Oncol Manag; 2004; 13(6):13-23. PubMed ID: 15648221
[TBL] [Abstract][Full Text] [Related]
14. Clinical benefits of once-weekly epoetin alfa in anemic patients with colorectal cancer receiving chemotherapy.
Chu E; Einhorn LH; Lefebvre P
J Support Oncol; 2006 May; 4(5):243-50. PubMed ID: 16724648
[TBL] [Abstract][Full Text] [Related]
15. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument.
Esper P; Mo F; Chodak G; Sinner M; Cella D; Pienta KJ
Urology; 1997 Dec; 50(6):920-8. PubMed ID: 9426724
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of fatigue levels in cancer patients at a Veterans Administration Medical Center.
Hwang SS; Chang VT; Cogswell J; Kasimis BS
Cancer; 2002 May; 94(9):2481-9. PubMed ID: 12015774
[TBL] [Abstract][Full Text] [Related]
17. Internal consistency of the traditional Chinese character version of the Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N).
Chang JT; Chang CH; Juang YY; Hsiao JC; Lin CY; Huang SF; Huang YC; Kuan KH; Liao CT; Wang HM; Chen IH
Chang Gung Med J; 2008; 31(4):384-94. PubMed ID: 18935797
[TBL] [Abstract][Full Text] [Related]
18. Measuring quality of life of Chinese cancer patients: A validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale.
Yu CL; Fielding R; Chan CL; Tse VK; Choi PH; Lau WH; Choy DT; O SK; Lee AW; Sham JS
Cancer; 2000 Apr; 88(7):1715-27. PubMed ID: 10738232
[TBL] [Abstract][Full Text] [Related]
19. Psychometric assessment of the MSAS-SF and the FACIT-Fatigue Scale in Spanish-speaking patients with cancer in Uruguay.
Dapueto JJ; Abreu Mdel C; Francolino C; Levin R
J Pain Symptom Manage; 2014 May; 47(5):936-45. PubMed ID: 24291293
[TBL] [Abstract][Full Text] [Related]
20. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
